These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37696943)

  • 1. Feasibility and potential of an MRI-based prostate cancer screening.
    Masone MC
    Nat Rev Urol; 2023 Oct; 20(10):578. PubMed ID: 37696943
    [No Abstract]   [Full Text] [Related]  

  • 2. ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI.
    Marsden T; Lomas DJ; McCartan N; Hadley J; Tuck S; Brown L; Haire A; Moss CL; Green S; Van Hemelrijck M; Coolen T; Santaolalla A; Isaac E; Brembilla G; Kopcke D; Giganti F; Sidhu H; Punwani S; Emberton M; Moore CM;
    BMJ Open; 2021 Sep; 11(9):e048144. PubMed ID: 34593491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
    Nam RK; Wallis CJ; Stojcic-Bendavid J; Milot L; Sherman C; Sugar L; Haider MA
    J Urol; 2016 Aug; 196(2):361-6. PubMed ID: 26880413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should we prepare a generation of radiologists for MRI-based prostate cancer screening?
    Puech P; Gutierrez PA; Berg-Løgager V; Villeirs G
    Eur Radiol; 2023 Oct; 33(10):7212-7214. PubMed ID: 37148351
    [No Abstract]   [Full Text] [Related]  

  • 5. Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
    Takahashi T
    Radiology; 2023 Nov; 309(2):e231177. PubMed ID: 37962502
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial.
    Raslan M; Mercader C; Lamb AD
    Eur Urol; 2022 May; 81(5):543-544. PubMed ID: 35105477
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness analysis of prostate cancer screening and MRI.
    Takahashi T
    World J Urol; 2024 Apr; 42(1):212. PubMed ID: 38578452
    [No Abstract]   [Full Text] [Related]  

  • 8. Future of screening for prostate cancer.
    Dahm P
    BMJ; 2017 Sep; 358():j4200. PubMed ID: 28928226
    [No Abstract]   [Full Text] [Related]  

  • 9. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
    Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
    Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro).
    Maffei D; Giganti F; Moore CM
    Urol Oncol; 2023 Feb; 41(2):88-91. PubMed ID: 35871993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.
    Rannikko A; Leht M; Mirtti T; Kenttämies A; Tolonen T; Rinta-Kiikka I; Kilpeläinen TP; Natunen K; Lilja H; Lehtimäki T; Raitanen J; Kujala P; Ronkainen J; Matikainen M; Petas A; Taari K; Tammela T; Auvinen A
    BJU Int; 2022 Aug; 130(2):193-199. PubMed ID: 34958531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
    Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
    Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate.
    Kohestani K; Månsson M; Arnsrud Godtman R; Stranne J; Wallström J; Carlsson S; Hellström M; Hugosson J
    Scand J Urol; 2021 Apr; 55(2):116-124. PubMed ID: 33612068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging.
    Marsden T; McCartan N; Hadley J; Tuck S; Brown L; Haire AJ; Moss CL; Green S; Van Hemelrijck M; Coolen T; Santaolalla A; Isaac E; Brembilla G; Kopcke D; Giganti F; Sidhu H; Punwani S; Emberton M; Moore CM;
    Eur Urol Focus; 2021 May; 7(3):503-505. PubMed ID: 33896710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography-The IP1-PROSTAGRAM Study-Reply.
    Eldred-Evans D; Ahmed HU
    JAMA Oncol; 2021 Oct; 7(10):1575-1576. PubMed ID: 34410324
    [No Abstract]   [Full Text] [Related]  

  • 17. MRI as a screening tool for prostate cancer: current evidence and future challenges.
    Würnschimmel C; Chandrasekar T; Hahn L; Esen T; Shariat SF; Tilki D
    World J Urol; 2023 Apr; 41(4):921-928. PubMed ID: 35226140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of prostate cancer: the implications and proper utilization of PSA and its variants; indications and use of MRI and biomarkers.
    Law KW; Nguyen DD; Barkin J; Zorn KC
    Can J Urol; 2020 Feb; 27(27 Suppl 1):3-10. PubMed ID: 32101694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study.
    Eldred-Evans D; Tam H; Sokhi H; Padhani AR; Connor M; Price D; Gammon M; Klimowska-Nassar N; Burak P; Day E; Winkler M; Fiorentino F; Ahmed HU
    Eur Urol Oncol; 2023 Jun; 6(3):295-302. PubMed ID: 37080821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study.
    Hao S; Heintz E; Östensson E; Discacciati A; Jäderling F; Grönberg H; Eklund M; Nordström T; Clements MS
    Eur Urol; 2022 Jul; 82(1):12-19. PubMed ID: 35094896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.